sefulness of Transesophageal Echocardiography Probe for the Diagnosis of Digestive Diseases - UTEP 3D study

Ishikawa Takuya0 sites1 target enrollmentMarch 13, 2019

Conditionspancreatic cancer, pancreatitis, esophageal varices, pancreatic cysts, esophageal/gastric cancer

Overview

Phase: 未知
Intervention: Not specified
Conditions: pancreatic cancer, pancreatitis, esophageal varices, pancreatic cysts, esophageal/gastric cancer
Sponsor: Ishikawa Takuya
Enrollment: 1
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

We presented the first case report that demonstrated the usefulness of 3D TEE in characterizing MCN of the pancreas. Our experience has indicated the possibility to apply real-time 3D ultrasonography for the assessment of pancreatic lesions. We hope an EUS probe equipped with a matrix transducer such as TEE will be developed in the near future.

Registry

who.int

Start Date

March 13, 2019

End Date

March 31, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Ishikawa Takuya

Eligibility Criteria

Inclusion Criteria

•(1\) Patients who have lesions in the esophagus or periesophageal region (e.g. lymph nodes, pancreas, liver) which can be observed with EUS. Specific examples are as follows:
•1\. Pancreatic cancers that require evaluation of invation to vessels.
•2\. Esophageal/gastric varices that need to select appropriate location for sclerosing therapy or require evaluation of therapeutic effect.
•3\. Acute pancreatitis that require evaluation of blood flow inside the pancreas
•4\. Pancreatic cystic neoplasms that require detailed evaluation of internal structures (real\-time evaluation of nodule, septum and mucus excluding partial volume effect).
•5\. Early stage esophageal/gastric cancers that require three dimentional evaluation of external wall vessels prior to endoscopic resection.
•(2\) Patients between 20 and 80 years old at the time of enrollment.
•(3\) Preservation of main organ functions at the time of diagnosis.
•(4\) Provision of written consent to participate in the study.